The New York Times – Business:
An Operation Warp Speed report last June flagged staffing and quality control concerns at Emergent BioSolutions’ factory in Baltimore. The troubled plant recently had to throw out up to 15 million doses.
This post first appeared in The New York Times – Business. Read the original article.
